UNIVERSITY OF CALIFORNIA, IRVINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1965-01-01

Employees: 10K

Market Cap: -

Website: http://www.uci.edu

Clinical Trials

Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds

Early Phase 1

Recruiting

Conditions: Open Wound
Wound Heal

Interventions: Drug: Micro/nanobubble (MNB) - Irrigation
Drug: Micro/nanobubble (MNB) - Negative Pressure Wound Therapy with Instillation (NPWTi)
Other: 0.9% Normal Saline - Negative Pressure Wound Therapy with Instillation (NPWTi)
Other: 0.9% Normal Saline - Irrigation

First Posted Date: 2021-12-27

Last Posted Date: 2024-05-08

Lead Sponsor: University of California, Irvine

Target Recruit Count: 40

Registration Number: NCT05169814

Locations: 🇺🇸
UCI Medical Center, Orange, California, United States

Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

Phase 4

Recruiting

Conditions: Myofascial Trigger Point Pain
Myofacial Pain

Interventions: Procedure: Trigger point injection with 1% lidocaine
Drug: Lidocaine patch 5%

First Posted Date: 2021-12-09

Last Posted Date: 2021-12-09

Lead Sponsor: University of California, Irvine

Target Recruit Count: 110

Registration Number: NCT05151510

Locations: 🇺🇸
Emergency Room at UCI Medical Center, Orange, California, United States

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

Phase 1

Recruiting

Conditions: Polycythemia Vera
Myelofibrosis
Myeloproliferative Neoplasm
Essential Thrombocythemia
MPN

Interventions: Drug: N-Acetylcysteine

First Posted Date: 2021-11-17

Last Posted Date: 2024-01-18

Lead Sponsor: University of California, Irvine

Target Recruit Count: 27

Registration Number: NCT05123365

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

Animal Assisted Intervention With Dogs for Children With ADHD

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: Behavioral Social Skills Training
Behavioral: Animal Assisted Intervention

First Posted Date: 2021-11-01

Last Posted Date: 2024-01-17

Lead Sponsor: University of California, Irvine

Target Recruit Count: 39

Registration Number: NCT05102344

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States

Sporadic Inclusion Body Myositis Natural History Study

Active, not recruiting

Conditions: Inclusion Body Myositis
Sporadic Inclusion Body Myositis

First Posted Date: 2021-09-16

Last Posted Date: 2024-04-09

Lead Sponsor: University of California, Irvine

Target Recruit Count: 150

Registration Number: NCT05046821

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States

and more 10 locations

Dietary Sodium Intake and Blood Pressure in Living Kidney Donors

Not Applicable

Suspended

Conditions: Hypertension
Living Kidney Donor
Dietary Sodium Intake

Interventions: Other: Dietary sodium

First Posted Date: 2021-09-13

Last Posted Date: 2024-08-20

Lead Sponsor: University of California, Irvine

Target Recruit Count: 24

Registration Number: NCT05041829

Locations: 🇺🇸
University of California Irvine Medical Center, Orange, California, United States

Using Nicotine to Reverse Age-related Auditory Processing Deficits

Not Applicable

Recruiting

Conditions: Auditory Perceptual Impairment
Aging

Interventions: Other: Placebo gum
Other: Nicotine gum

First Posted Date: 2021-07-22

Last Posted Date: 2023-05-17

Lead Sponsor: University of California, Irvine

Target Recruit Count: 48

Registration Number: NCT04971954

Locations: 🇺🇸
Hearing and Speech Lab, Irvine, California, United States

Study of CtDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Phase 1

Recruiting

Conditions: Colon Adenocarcinoma
Colorectal Cancer

Interventions: Drug: TAS-102
Drug: Irinotecan
Combination Product: Standard Treatment
Diagnostic Test: Signatera MRD ctDNA Assay

First Posted Date: 2021-06-09

Last Posted Date: 2024-11-06

Lead Sponsor: University of California, Irvine

Target Recruit Count: 22

Registration Number: NCT04920032

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Dementia Family Caregiver Study

Not Applicable

Recruiting

Conditions: Dementia Caregiver

Interventions: Behavioral: Community Health Worker (CHW) Home Visit Intervention
Behavioral: Attention Control Group with WIoT Technology
Behavioral: Usual Care

First Posted Date: 2021-05-20

Last Posted Date: 2024-02-28

Lead Sponsor: University of California, Irvine

Target Recruit Count: 332

Registration Number: NCT04894006

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States

Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy

Phase 1

Active, not recruiting

Conditions: Colorectal Cancer
Colorectal Carcinoma
Metastatic Cancer
CRC

Interventions: Drug: Cabozantinib
Drug: TAS-102

First Posted Date: 2021-05-03

Last Posted Date: 2024-04-01

Lead Sponsor: University of California, Irvine

Target Recruit Count: 12

Registration Number: NCT04868773

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy